Publicador de contenidos

Back to 2014_06_16_CIE_doctor-prosper

Dr. Prósper: "Obtaining reprogrammed cells opens new expectations in cell therapy".

The specialist in hematology and cell therapy participates in the presentation of the Master's Degree in research Biomedical of the University of Navarra.

Image description
Dr. Prósper
PHOTO: Manuel Castells
16/06/14 10:47 Laura Latorre

"Obtaining reprogrammed cells has opened up new expectations in the field of cell therapy, given that their production is not controversial from an ethical point of view". These are the words of Dr. Felipe Prósper, a specialist in hematology and cell therapy, who will speak about the latest advances in stem cell s during the presentation of the newMaster's Degree at research Biomedical of the University of Navarra.

According to the expert, one of the most important discoveries in recent years has been the possibility of inducing the reprogramming of somatic cells of the organism. That is, "to transform a fully differentiated adult stem cell into a pluripotent cell, with unlimited capacity to proliferate and differentiate into any tissue subject ".

The professor, who will give the lecture lecture "From stem cells to cell therapy: Medicine of the future?", points out that "the presence of stem cells capable of regenerating the hematopoietic system has been used successfully for more than 60 years, with the goal to treat different diseases such as leukemias or lymphomas, thanks to bone marrow transplantation". However, he stresses that the demonstration of the existence of these cells in the brain or in the human heart has only recently been described and "we are at the beginning of understanding the principles that regulate their capacity to regenerate these tissues".

Dr. Prosper will explain the applications of adult stem cells"which are being investigated for the treatment of a multitude of diseases, from neurodegenerative diseases to trauma or myocardial infarction" and distinguishes between regenerative medicine - the best known and with the greatest impact -, gene therapy and the use of stem cells in the development of new drugs. In this respect, he indicates that more than 99% of clinical trials are being carried out with this subject of cells as opposed to embryonic cells. subject "Precisely because of the greater capacity for proliferation and differentiation to different types of tissues of these cells, when they are injected into experimental animals they frequently generate tumors and their control is much more difficult than in the case of adult cells," he stresses.

New Master's Degree at research Biomedica

The Master's Degree in research Biomedical of the University of Navarra offers a specific and qualifiedtraining so that the student body can face the current challenges of research in biomedicine, biotechnology and health. Hence, it is organized in four specialties that coincide with the lines of research that are carried out in the Schools of Medicine, Sciences and Pharmacy, the research center Applied Medical and the Clínica Universidad de Navarraand which are: Cancer, research Translational, Neuroscience and Cognition, and Nutrition and Metabolism. The presentation of the postgraduate program will be held tomorrow June 17, at 19:30 pm, at the headquarters of ISEM Fashion Business School (C/Zurbano, 73, Madrid).